A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools

Author:

Thuy Matthew N.T.,Kam Jeremy K.T.,Lee Geoffrey C.Y.,Tao Peter L.,Ling Dorothy Q.,Cheng Melissa,Goh Su Kah,Papachristos Alexander J.,Shukla Lipi,Wall Krystal-Leigh,Smoll Nicolas R.,Jones Jordan J.,Gikenye Njeri,Soh Bob,Moffat Brad,Johnson Nick,Drummond Katharine J.

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,General Medicine,Surgery

Reference312 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;Engl J Med,2005

2. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide;Hegi;Clin Cancer Res,2004

3. Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy;Dunn;Br J Cancer,2009

4. Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin;Park;Neuropathology,2009

5. Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker;Preusser;Brain Pathol,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3